UK markets closed

OBI Pharma, Inc. (4174.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
59.20+0.60 (+1.02%)
At close: 01:30PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
6,714
41,549
4,711
18,772
140,886
Cost of revenue
51,050
115,046
44,855
44,362
6,469
Gross profit
-44,336
-73,497
-40,144
-25,590
134,417
Operating expenses
Research development
1,766,824
1,697,017
1,772,856
1,449,598
1,309,881
Selling general and administrative
277,873
319,277
309,762
240,826
290,417
Total operating expenses
2,044,697
2,016,294
2,082,618
1,690,424
1,600,298
Operating income or loss
-2,089,033
-2,089,791
-2,122,762
-1,716,014
-1,465,881
Interest expense
4,189
7,937
3,990
3,798
4,184
Income before tax
-1,862,726
-1,275,554
-1,917,092
-1,742,253
-1,493,691
Income tax expense
-3,053
-9,594
-17,768
-24,363
-3,794
Income from continuing operations
-1,859,673
-1,265,960
-1,899,324
-1,717,890
-1,489,897
Net income
-1,594,892
-1,046,475
-1,613,916
-1,530,687
-1,377,935
Net income available to common shareholders
-1,594,892
-1,046,475
-1,613,916
-1,530,687
-1,377,935
Basic EPS
-4.83
-4.57
-7.27
-7.69
-7.27
Diluted EPS
-4.83
-4.57
-7.27
-7.69
-7.27
Basic average shares
229,116
228,988
221,997
198,941
200,600
Diluted average shares
229,116
228,988
221,997
198,941
200,600